Adoptive Cellular Immunotherapy Market

Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
Adoptive Cellular Immunotherapy Market contains market size and forecasts of Adoptive Cellular Immunotherapy in Global, including the following market information:
Global Adoptive Cellular Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Adoptive Cellular Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
TIL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Adoptive Cellular Immunotherapy include Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp and Cell Medica Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adoptive Cellular Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adoptive Cellular Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Adoptive Cellular Immunotherapy Market Segment Percentages, by Type, 2021 (%)
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Other
Global Adoptive Cellular Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Adoptive Cellular Immunotherapy Market Segment Percentages, by Application, 2021 (%)
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other
Global Adoptive Cellular Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Adoptive Cellular Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adoptive Cellular Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Adoptive Cellular Immunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc